Search results
Pfizer Inc. (PFE): Is It Worth A Small Bite At $28.27? – Stocks Register
Stocks Register· 1 day agoPfizer Inc. (NYSE:PFE) price on Wednesday, May 09, rose 1.80% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $28.27. A look at ...
Sanofi Inks $1.2 Billion Vaccine Licensing Deal With Novavax
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Sanofi and Novavax Inc. signed a licensing agreement that includes commercializing a...
Patient dies in Pfizer study of Duchenne gene therapy
BioPharma Dive via Yahoo Finance· 3 days agoPfizer said the patient, a young boy who was treated earlier last year, died suddenly from cardiac...
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 6 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 6 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 2 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 4 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 3 days agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg· 2 days agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...